T2细菌检测板在儿科造血细胞移植和细胞治疗患者中的应用：单中心经验
Use of T2Bacteria Panel in Pediatric Hematopoietic Cell Transplant and Cellular Therapy Patients: A Single-Center Experience.
作者信息
Hiskey Lisa, Glasgow Heather L, Hijano Diego, Ferrolino Jose, Dallas Ronald, Madden Renee M, Maron Gabriela, Hayden Randall T
机构信息
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States.
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States.
出版信息
J Pediatric Infect Dis Soc. 2025 Aug 7;14(7). doi: 10.1093/jpids/piaf059.
Abstract
We evaluated the use of the T2Bacteria panel for diagnosis of bloodstream infection in pediatric HCT/CT patients. Overall, the panel expedited recognition of bloodstream infections, providing results sooner than Gram stain and final blood culture identification. The T2Bacteria panel contributed to a change to appropriate therapy in 23% of patients with concordant positive results.
摘要
我们评估了T2Bacteria检测板在儿科造血干细胞移植/化疗患者血流感染诊断中的应用。总体而言，该检测板加快了血流感染的识别速度，比革兰氏染色和最终血培养鉴定更快地提供结果。在23%检测结果一致为阳性的患者中，T2Bacteria检测板促使治疗方案改为适当的治疗。
相似文献
1
Use of T2Bacteria Panel in Pediatric Hematopoietic Cell Transplant and Cellular Therapy Patients: A Single-Center Experience.
J Pediatric Infect Dis Soc. 2025 Aug 7;14(7). doi: 10.1093/jpids/piaf059.
2
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.
Transplant Cell Ther. 2025 May 19. doi: 10.1016/j.jtct.2025.05.014.
3
Effects of Total Body Irradiation on Hematopoietic Cell Transplantation Outcomes in Pediatric Acute Myeloid Leukemia with Prior Central Nervous System Involvement.
Transplant Cell Ther. 2024 Aug;30(8):812.e1-812.e11. doi: 10.1016/j.jtct.2024.05.014. Epub 2024 May 18.
4
A single-center retrospective study of pathogen distribution and antibiotic resistance of bloodstream infections in emergency department.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1799-1807. doi: 10.11817/j.issn.1672-7347.2024.240333.
5
Bloodstream Infections Due to Multidrug-Resistant Gram-Negative Organisms in Hematopoietic Stem Cell Transplant Recipients: A Multicenter Case-Control Study in a High-Prevalence Area.
Transplant Cell Ther. 2025 Aug;31(8):596.e1-596.e12. doi: 10.1016/j.jtct.2025.05.007. Epub 2025 May 14.
6
Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.
Transplant Cell Ther. 2024 Oct;30(10):1017.e1-1017.e12. doi: 10.1016/j.jtct.2024.07.022. Epub 2024 Jul 31.
7
Impact of the BioFire® BCID2 panel on antimicrobial treatment and mortality in pediatric gram-negative bloodstream infections.
Diagn Microbiol Infect Dis. 2025 Nov;113(3):117003. doi: 10.1016/j.diagmicrobio.2025.117003. Epub 2025 Jul 11.
8
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther. 2023 Dec;29(12):778.e1-778.e6. doi: 10.1016/j.jtct.2023.09.011. Epub 2023 Sep 21.
9
Diagnostic accuracy and clinical impact of filmarray multiplex PCR system in bloodstream infections: A comparative study with conventional methods in a tertiary health care setting.
Medicine (Baltimore). 2025 Jul 18;104(29):e43263. doi: 10.1097/MD.0000000000043263.
10
Association between time to gram stain positivity and true bacteremia in pediatric emergency department patients.
Am J Emerg Med. 2025 Sep;95:72-76. doi: 10.1016/j.ajem.2025.05.019. Epub 2025 May 17.
本文引用的文献
1
Point-of-Care Method T2BacteriaPanel Enables a More Sensitive and Rapid Diagnosis of Bacterial Blood Stream Infections and a Shorter Time until Targeted Therapy than Blood Culture.
Microorganisms. 2024 May 11;12(5):967. doi: 10.3390/microorganisms12050967.
2
Incidence, Risk Factors and Outcome of Bloodstream Infections in Patients After Hematopoietic Stem-Cell Transplantation: A Single Center Study.
Indian J Hematol Blood Transfus. 2023 Apr 1;39(4):1-5. doi: 10.1007/s12288-023-01645-2.
3
Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
J Clin Oncol. 2023 Mar 20;41(9):1774-1785. doi: 10.1200/JCO.22.02224. Epub 2023 Jan 23.
4
Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population.
J Clin Microbiol. 2022 Oct 19;60(10):e0029222. doi: 10.1128/jcm.00292-22. Epub 2022 Sep 7.
5
Molecular diagnosis of bacteremia in a pediatric intensive care unit: a step forward.
Future Microbiol. 2022 May;17:505-510. doi: 10.2217/fmb-2021-0154. Epub 2022 Mar 22.
6
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience.
BMC Infect Dis. 2022 Feb 1;22(1):113. doi: 10.1186/s12879-022-07096-w.
7
In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series.
BMC Infect Dis. 2020 May 7;20(1):326. doi: 10.1186/s12879-020-05049-9.
8
The T2Bacteria Assay Is a Sensitive and Rapid Detector of Bacteremia That Can Be Initiated in the Emergency Department and Has Potential to Favorably Influence Subsequent Therapy.
J Emerg Med. 2020 May;58(5):785-796. doi: 10.1016/j.jemermed.2019.11.028. Epub 2020 Jan 23.
9
Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
Pediatr Transplant. 2020 Feb;24(1):e13610. doi: 10.1111/petr.13610. Epub 2019 Nov 4.
10
Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study.
Ann Intern Med. 2019 Jun 18;170(12):845-852. doi: 10.7326/M18-2772. Epub 2019 May 14.
Zotero 插件